Navigation Links
Biological H1N1 Vaccines: Too Little, Too Late
Date:11/25/2009

n H5N1, the Replikin Counts in the same two genes exhibit the reverse characteristics, that is, low infectivity and high lethality (Figure); and in this case again, the Counts correspond to what follows clinically, that is, low infectivity and high lethality cases. The distinctly separate and opposite states in these genes is therefore observed both intra-strain in H1N1, and inter-strain in H1N1 vs. H5N1. This represents an important validation by the method of "double differentiation" of the independent function of these two genes (refs). Dr. Samuel Bogoch is co-founder with Dr. Elenore Bogoch of Replikins Ltd., a Boston biotechnology firm which attracted worldwide attention for successfully predicting the current H1N1 outbreak a full year ahead of time. Dr. Bogoch is again making waves by stating that as of this month, this cycle of the outbreak has peaked. FluForecast(R) is showing declining levels of key Replikins sequences in the virus. High levels of these sequences have been consistently linked with the lethality of viruses in major epidemics, and their reduction is indicative that the current outbreak is declining from a peak level earlier this year. The Company has announced the formation of WorldVaccines(TM) Ltd to test and distribute FluForecast(R) and Replikins' synthetic vaccines against emerging diseases to address the "niche" of 6 billion people who are not receiving timely biological vaccines.

Logo: http://www.ereleases.com/pr/2009-Replikins-Logo.jpg

References:

1) US Patent Office publications on Replikins 2002-2009; 2) BogochS, Bogoch,ES. Replikins: the Biochemistry of Rapid Replication, Begell House, New York, 2005; 3) Website <replikins.com> Replikins Press 2006-2009; 4) CDC Weekly Reports website (google "FluView"); 5) Betsy McKay, Wall Street Journal, page A3, November 21-22, 2009; 6) Jackwood, M. et al. Efficacy of a Replik
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference
2. Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India
3. New Non-Biological Synthetic Replikins(TM) Vaccines Shown to Be Effective and Fast; WorldVaccines(TM), Ltd Formed for Testing and Distribution
4. Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
5. Scientists use math modeling to predict unknown biological mechanism of regulation
6. Quantel Signs a Distribution Agreement With US-based National Biological
7. Senate President Therese Murray, Massachusetts Life Sciences Center, and Howard Hughes Medical Institute Join Marine Biological Laboratory (MBL) for Loeb Laboratory Groundbreaking Ceremony
8. Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification
9. Nucleix Researchers Discover DNA Evidence May Easily be Falsified: Company Develops New Detection Technology for Preventing Biological Identity Theft
10. Nanoelectronic transistor combined with biological machine could lead to better electronics
11. Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Childrens Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... The Center for Professional Innovation ... training across the life sciences industry, has partnered with ... to provide the organization's members with discounted classroom courses, ... the more than 350 sessions across 80 course titles. ... when registering for a public course at ...
(Date:12/22/2014)... 2014 GenomeDx Biosciences today announced that a ... a genomic test for prostate cancer, was able to ... by radical prostatectomy without adjuvant therapy. Although rapid metastasis ... using tumor genomics to identify these men who have ... important advance. The study has been published online ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Fertility Associates ... Donor Egg Bank USA , a network of more ... Through this partnership, patients have fast access to a ... vitro fertilization, IVF . Fertility Associates of Memphis is ... this fertility treatment option. , Dr. William Kutteh ...
(Date:12/19/2014)... -- Naurex Inc., a biopharmaceutical company leveraging its unique ... central nervous system, today announced that Norbert Riedel ... at the 33 rd annual J.P. Morgan Healthcare ... p.m. PST on Tuesday, January 13, 2015, at the ... About Naurex Inc. ...
Breaking Biology Technology:CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... Pharmaceuticals,Inc. (Nasdaq: VNDA ), a biopharmaceutical company ... candidates for central,nervous system disorders, today announced financial ... 30, 2008., Vanda reported research and development ... $3.8 million, compared to $5.5 million in the ...
... Identify Predisposition to Early Cardiovascular,Events in Asian Populations, ... (Amex: ILI ), announced today that Kenneth ... new research findings on,the genetics of cardiovascular disease ... which takes place from Oct. 31 -,Nov. 1, ...
... on the DBTSS, Pfam and PDB databases enable ,researchers to quickly ... ... 2008 -- OpenHelix today announced the availability of newly updated ... the Protein Databank (PDB). DBTSS is a public resource for ...
Cached Biology Technology:Vanda Pharmaceuticals Reports Third Quarter 2008 Results 2Vanda Pharmaceuticals Reports Third Quarter 2008 Results 3Vanda Pharmaceuticals Reports Third Quarter 2008 Results 4Vanda Pharmaceuticals Reports Third Quarter 2008 Results 5Vanda Pharmaceuticals Reports Third Quarter 2008 Results 6Vanda Pharmaceuticals Reports Third Quarter 2008 Results 7Vanda Pharmaceuticals Reports Third Quarter 2008 Results 8Vanda Pharmaceuticals Reports Third Quarter 2008 Results 9Vanda Pharmaceuticals Reports Third Quarter 2008 Results 10Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 2Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 3Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium 4Updated Online Tutorials for DBTSS, Pfam and PDB 2Updated Online Tutorials for DBTSS, Pfam and PDB 3
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical ... building for its School of Medicine. Funding for this ... capital campaign that will be publicly launched next summer. ... located in the former 60 series R.J. Reynolds Tobacco ... Quarter. Construction will begin immediately with plans to be ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... at the Institute of Food Research, which is ... of virus-produced proteins that destroy bacterial cells to ... proteins that specifically target certain bacteria, and IFR ... difficile , a common and dangerous source of ...
... five-year grant is considered a long-term grant, Alan R. Templeton, PhD, ... in St. Louis, has managed to follow some of the species ... in his career he studied parthenogenesis, or virgin birth, in fruit ... "Drosophilia have fast generation times," he says, "but I studied ...
... ReportsnReports   announces it will carry Market Research Reports on ... Image-Guided Surgery)   in its store A. ... Cell Arrays) Trends & Global Forecast (2010-2015) ... key applications. It was valued at $2.6 billion in 2010 ...
Cached Biology News:Tuning natural antimicrobials to improve their effectiveness at battling superbugs 2Restoration as science: case of the collared lizard 2Restoration as science: case of the collared lizard 3Restoration as science: case of the collared lizard 4Restoration as science: case of the collared lizard 5Restoration as science: case of the collared lizard 6Restoration as science: case of the collared lizard 7Restoration as science: case of the collared lizard 8Restoration as science: case of the collared lizard 9ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research 2ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research 3ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research 4ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research 5
... quadrupole 1200L sets the new standard ... - incorporating the latest technologies and ... chromatography analytical needs. The Atmospheric ... Transmission Quadrupole Analyzer provide superior selectivity ...
Human GFR alpha-4 Affinity Purified Polyclonal Ab...
Human Siglec-9 Biotinylated Affinity Purified Pab...
Human MFRP MAb (Clone 291218)...
Biology Products: